Amubarvimab, CAS 2509447-07-6

Product Description: Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Ji Y, et, al. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Front Immunol. 2022 Sep 14;13:980435. /[2]Hoy SM. Amubarvimab/Romlusevimab: First Approval. Drug. 2022 Aug;82(12):1327-1331.

CAS Number: 2509447-07-6

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Infection

Solubility: H2O

Target: SARS-CoV

• Artikelnummer: MEXHY-P99435-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99435-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK